Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study.

Literature DB >> 7981447

Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study.

J M Bhatavdekar¹, D D Patel, N H Karelia, H H Vora, N Ghosh, N G Shah, D B Balar, S N Trivedi.

Abstract

A retrospective study was performed on 69 breast cancer patients (stage II, N = 18; advanced disease, N = 51) in order to assess the prognostic value of circulating prolactin (PRL), CEA, CA 15-3, insulin-like growth factor-1 (IGF-1), and epidermal growth factor (EGF) by RIA/IRMA. These markers were compared with short-term prognosis (two years). Significant difference was observed only for PRL ( < 20.0 ng/ml vs. > 20.0 ng/ml), which provide an independent predictor of short-term prognosis in advanced breast cancer.

Entities: Disease Gene Species

Mesh：

Substances：

Year: 1994 PMID： 7981447 DOI： 10.1007/BF00665970

Source DB: PubMed Journal: Breast Cancer Res Treat ISSN： 0167-6806 Impact factor: 4.872

14 in total

1. Radioimmunoassayable insulin-like growth factor-I in human breast cyst fluid.

Authors: D Y Wang; H Hamed; C I Mockridge; I S Fentiman
Journal: Eur J Cancer Clin Oncol Date: 1989-05

2. Expression of the c-erbB-2 protein in normal and transformed cells.

Authors: W J Gullick; M S Berger; P L Bennett; J B Rothbard; M D Waterfield
Journal: Int J Cancer Date: 1987-08-15 Impact factor: 7.396

Review 3. Cathepsin D in breast cancer.

Authors: H Rochefort
Journal: Breast Cancer Res Treat Date: 1990-07 Impact factor: 4.872

4. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.

Authors: J A Foekens; H Portengen; M Janssen; J G Klijn
Journal: Cancer Date: 1989-06-01 Impact factor: 6.860

5. Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patients.

Authors: F Spyratos; K Hacene; M Tubiana-Hulin; C Pallud; M Brunet
Journal: Eur J Cancer Clin Oncol Date: 1989-08

6. Steroid receptors in human breast cancer.

Authors: W L McGuire
Journal: Cancer Res Date: 1978-11 Impact factor: 12.701

7. Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.

Authors: J M Bhatavdekar; D B Balar; N G Shah; S N Trivedi; A Bhaduri; D D Patel; N H Karelia; M K Shukla; N Ghosh
Journal: Tumour Biol Date: 1987

Tumor markers in patients with advanced breast cancer as prognosticators: a preliminary study.

1. Radioimmunoassayable insulin-like growth factor-I in human breast cyst fluid.

2. Expression of the c-erbB-2 protein in normal and transformed cells.

Review 3. Cathepsin D in breast cancer.

4. Insulin-like growth factor-1 receptors and insulin-like growth factor-1-like activity in human primary breast cancer.

5. Prognostic value of estrogen and progesterone receptors in primary infiltrating ductal breast cancer. A sequential multivariate analysis of 1262 patients.

6. Steroid receptors in human breast cancer.

7. Prognosis in breast carcinoma utilizing plasma carcinoembryonic antigen and histologic characteristics of the primary tumor.

8. Prognostic value of epidermal growth factor receptor in node-positive breast cancer.

9. EGF in breast cyst fluid: relationships with intracystic androgens, estradiol and progesterone.

10. CA 15.3 as a tumour marker in breast cancer.

Review 1. The role of circulating IGF-I: lessons from human and animal models.

2. Prognostic value of epidermal growth factor expression in breast cancer.

Review 3. Insulin-like growth factors and insulin-like growth factor binding proteins in mammary gland function.

4. Biomarkers of the metabolic syndrome and breast cancer prognosis.